While there have been several studies examining Bcl-2 expression with ovarian tumor progression or the prognostic importance of the presence of lymphocytes for clinical outcome in ovarian cancer, our study is the first to examine Bcl-2 expression in both epithelial and stromal cells as well as lymphocyte distribution with ovarian cancer progression. This evidence concerns the gene BCL2 and ovarian neoplasm.